In these studies, the safety profile of retatrutide was found to be on par with that of other incretin mimetics like tirzepatide [21, 27]
Existing studies generally suggest that, by alleviating the obesity/IRhyperandrogenism cascade, GLP-1RAs bring the HPO axis closer to a physiological state
A GLP-1 weight loss plateau is a period when weight loss slows or temporarily stops during treatment, even though the medication may still be helping with appetite, food noise, portion control, and metabolic health
Abstract It is known that textile dyes have various risks on human health
Over 50% of patients lost 15% body weight, a threshold rarely achieved with other anti-obesity medications
Nanoparticles (NPs) loaded with MB could offer a more effective treatment for Alzheimers and related disorders [32]